Elizabeth Iorns

3.3k total citations · 2 hit papers
52 papers, 2.3k citations indexed

About

Elizabeth Iorns is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Elizabeth Iorns has authored 52 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Cancer Research. Recurrent topics in Elizabeth Iorns's work include RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer-related molecular mechanisms research (6 papers). Elizabeth Iorns is often cited by papers focused on RNA modifications and cancer (7 papers), Cancer Cells and Metastasis (6 papers) and Cancer-related molecular mechanisms research (6 papers). Elizabeth Iorns collaborates with scholars based in United States, United Kingdom and Netherlands. Elizabeth Iorns's co-authors include Nicholas C. Turner, Christopher J. Lord, Alan Ashworth, Andrew Tutt, Timothy M. Errington, Brian A. Nosek, Nicole Perfito, Jorge S. Reis‐Filho, Richard Elliott and Alan Mackay and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Nature Reviews Drug Discovery.

In The Last Decade

Elizabeth Iorns

49 papers receiving 2.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer

2010 544 citations Nicholas C. Turner, Alex Pearson et al. Cancer Research profile →
Investigating the replicability of preclinical cancer biology

2021 170 citations Timothy M. Errington, Maya B. Mathur et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Iorns United States	19	1.5k	796	522	280	228	52	2.3k
Thomas Schlange Germany	21	1.4k 0.9×	536 0.7×	492 0.9×	201 0.7×	171 0.8×	32	2.7k
Martin Fenner Germany	25	1.1k 0.7×	370 0.5×	359 0.7×	361 1.3×	249 1.1×	198	2.2k
Laura Ponting United Kingdom	7	1.5k 1.0×	326 0.4×	593 1.1×	225 0.8×	365 1.6×	8	2.2k
Jason M. Sheltzer United States	22	1.4k 0.9×	433 0.5×	609 1.2×	164 0.6×	354 1.6×	35	2.7k
Jennifer A. Byrne Australia	31	1.5k 1.0×	540 0.7×	557 1.1×	280 1.0×	284 1.2×	114	2.9k
Olga Potapova United States	26	2.4k 1.6×	815 1.0×	554 1.1×	186 0.7×	220 1.0×	42	3.2k
Patrick R. Blackburn United States	19	923 0.6×	250 0.3×	235 0.5×	130 0.5×	328 1.4×	74	1.7k
Laura Bonetta United States	21	1.4k 0.9×	396 0.5×	138 0.3×	206 0.7×	282 1.2×	102	2.0k
Theodora Bloom United States	11	700 0.5×	759 1.0×	130 0.2×	75 0.3×	188 0.8×	26	1.4k
Peter Riegman Netherlands	31	1.9k 1.3×	513 0.6×	766 1.5×	924 3.3×	505 2.2×	70	3.8k

Countries citing papers authored by Elizabeth Iorns

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Iorns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Iorns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Iorns more than expected).

Fields of papers citing papers by Elizabeth Iorns

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Iorns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Iorns. The network helps show where Elizabeth Iorns may publish in the future.

Co-authorship network of co-authors of Elizabeth Iorns

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Iorns. A scholar is included among the top collaborators of Elizabeth Iorns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Iorns. Elizabeth Iorns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Errington, Timothy M., Maya B. Mathur, Courtney K. Soderberg, et al.. (2021). Investigating the replicability of preclinical cancer biology. eLife. 10. 170 indexed citations breakdown →

Wang, Hongyan, Hanna S. Radomska, Mitch A. Phelps, et al.. (2020). Replication Study: Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs. eLife. 9. 5 indexed citations

Iorns, Elizabeth, et al.. (2020). Replication Study: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. eLife. 9. 5 indexed citations

Chen, Biao, Yongli Shan, Huajun Yang, et al.. (2019). Replication Study: The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44. eLife. 8. 18 indexed citations

Lewis, L. Michelle, Meredith Claire Edwards, C. Conover Talbot, et al.. (2018). Replication Study: Transcriptional amplification in tumor cells with elevated c-Myc. eLife. 7. 26 indexed citations

Repass, John, Elizabeth Iorns, Alexandria Denis, et al.. (2018). Replication Study: Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. eLife. 7. 46 indexed citations

Eaton, Kathryn A., Ali Pirani, Evan S. Snitkin, et al.. (2018). Replication Study: Intestinal inflammation targets cancer-inducing activity of the microbiota. eLife. 7. 11 indexed citations

Maalouf, Samar, Elizabeth Iorns, Rachel Tsui, et al.. (2018). Replication Study: Systematic identification of genomic markers of drug sensitivity in cancer cells. eLife. 7. 18 indexed citations

Fiehn, Oliver, Nicole Perfito, Kermit L. Carraway, et al.. (2013). Study 16: Replication of Ward et al., 2010 (Cancer Cell). OSF Preprints (OSF Preprints). 2 indexed citations

10.

Perfito, Nicole, Biao Chen, Huajun Yang, et al.. (2013). Study 28: Replication of Liu et al., 2011 (Nature Medicine). OSF Preprints (OSF Preprints). 1 indexed citations

11.

Perfito, Nicole, Stephen A. Williams, Timothy M. Errington, et al.. (2013). Study 50: Replication of Castellarin et al., 2012 (Genome Research). OSF Preprints (OSF Preprints). 1 indexed citations

12.

Perfito, Nicole, James Evans, Alexandria Denis, et al.. (2013). Study 9: Replication of Vermeulen et al., 2010 (Nature Cell Biology). OSF Preprints (OSF Preprints). 1 indexed citations

13.

Snitkin, Evan S., Nicole Perfito, Alexandria Denis, et al.. (2013). Study 41: Replication of Arthur et al., 2012 (Science). OSF Preprints (OSF Preprints). 1 indexed citations

14.

Tsui, Rachel, Alexandria Denis, Mitch A. Phelps, et al.. (2013). Study 24: Replication of Tay et al., 2011 (Cell). OSF Preprints (OSF Preprints). 1 indexed citations

15.

Iorns, Elizabeth, Ranjita Sengupta, Jeewon Kim, et al.. (2013). Study 42: Replication of Peinado et al., 2012 (Nature Medicine). OSF Preprints (OSF Preprints). 1 indexed citations

16.

Maalouf, Samar, Elizabeth Iorns, Rachel Tsui, et al.. (2013). Study 37: Replication of Garnett et al., 2012 (Nature). OSF Preprints (OSF Preprints). 1 indexed citations

17.

Jegg, Anna-Maria, Toby M. Ward, Elizabeth Iorns, et al.. (2012). PI3K independent activation of mTORC1 as a target in lapatinib-resistant ERBB2+ breast cancer cells. Breast Cancer Research and Treatment. 136(3). 683–692. 32 indexed citations

18.

Ward, Toby M., Elizabeth Iorns, Nicholas Hoe, et al.. (2012). Truncated p110 ERBB2 induces mammary epithelial cell migration, invasion and orthotopic xenograft formation, and is associated with loss of phosphorylated STAT5. Oncogene. 32(19). 2463–2474. 34 indexed citations

19.

Turner, Nicholas C., Alex Pearson, Rachel Sharpe, et al.. (2010). FGFR1 Amplification Drives Endocrine Therapy Resistance and Is a Therapeutic Target in Breast Cancer. Cancer Research. 70(5). 2085–2094. 544 indexed citations breakdown →

20.

Lord, Christopher J., Elizabeth Iorns, & Alan Ashworth. (2008). Dissecting resistance to endocrine therapy in breast cancer. Cell Cycle. 7(13). 1895–1898. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact